GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Magle Chemoswed Holding AB (OSTO:MAGLE) » Definitions » EV-to-EBITDA

Magle Chemoswed Holding AB (OSTO:MAGLE) EV-to-EBITDA : 13.60 (As of May. 21, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Magle Chemoswed Holding AB EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Magle Chemoswed Holding AB's enterprise value is kr424.4 Mil. Magle Chemoswed Holding AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was kr31.2 Mil. Therefore, Magle Chemoswed Holding AB's EV-to-EBITDA for today is 13.60.

The historical rank and industry rank for Magle Chemoswed Holding AB's EV-to-EBITDA or its related term are showing as below:

OSTO:MAGLE' s EV-to-EBITDA Range Over the Past 10 Years
Min: 8.69   Med: 13.73   Max: 35.04
Current: 13.6

During the past 6 years, the highest EV-to-EBITDA of Magle Chemoswed Holding AB was 35.04. The lowest was 8.69. And the median was 13.73.

OSTO:MAGLE's EV-to-EBITDA is ranked worse than
57.68% of 456 companies
in the Biotechnology industry
Industry Median: 10.52 vs OSTO:MAGLE: 13.60

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-21), Magle Chemoswed Holding AB's stock price is kr33.20. Magle Chemoswed Holding AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was kr1.130. Therefore, Magle Chemoswed Holding AB's PE Ratio for today is 29.38.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Magle Chemoswed Holding AB EV-to-EBITDA Historical Data

The historical data trend for Magle Chemoswed Holding AB's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Magle Chemoswed Holding AB EV-to-EBITDA Chart

Magle Chemoswed Holding AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial - 33.48 19.58 12.80 10.36

Magle Chemoswed Holding AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.22 14.13 16.22 10.36 13.25

Competitive Comparison of Magle Chemoswed Holding AB's EV-to-EBITDA

For the Biotechnology subindustry, Magle Chemoswed Holding AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Magle Chemoswed Holding AB's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Magle Chemoswed Holding AB's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Magle Chemoswed Holding AB's EV-to-EBITDA falls into.



Magle Chemoswed Holding AB EV-to-EBITDA Calculation

Magle Chemoswed Holding AB's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=424.438/31.219
=13.60

Magle Chemoswed Holding AB's current Enterprise Value is kr424.4 Mil.
Magle Chemoswed Holding AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr31.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Magle Chemoswed Holding AB  (OSTO:MAGLE) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Magle Chemoswed Holding AB's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=33.20/1.130
=29.38

Magle Chemoswed Holding AB's share price for today is kr33.20.
Magle Chemoswed Holding AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1.130.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Magle Chemoswed Holding AB EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Magle Chemoswed Holding AB's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Magle Chemoswed Holding AB (OSTO:MAGLE) Business Description

Traded in Other Exchanges
N/A
Address
Agneslundsvagen 27, Malmo, SWE, 21215
Magle Chemoswed Holding AB is a contract development and manufacturing organization that serves companies in the pharmaceutical and medical device industry on a contract basis. It provides comprehensive services from product development through product manufacturing. The company's products portfolio includes Warfarin sodium, Melperone hydrochloride, Isradipine, Amantadine sulfate, and Benserazide hydrochloride.

Magle Chemoswed Holding AB (OSTO:MAGLE) Headlines

No Headlines